Spot Reduction in Male Adults

March 31, 2023 updated by: Molde University College

The Assessment of Spot Reduction in Adults Males Following Endurance Training

Spot reduction, referring to local body fat reduction, pertains to subcutaneous adipose tissue utilization from specific body parts during exercise. Its existence has been keenly debated, although generally accepted not to occur during exercise. However, it is based on not only equivocal data - commonly the training protocol typically applied is based on strength rather than endurance training. The investigators sought to test this assumption by utilizing endurance based exercise controlling for energy expenditure and using dual x-ray absorptiometric measures to assess body composition before and after training.

Study Overview

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • males
  • ≥ 30 years old
  • classified as overweight (Body mass index ≥ 25 kg ∙ m-2)
  • not participating in regular physical training

Exclusion Criteria:

  • < 30 years old
  • Body mass index < 25 kg ∙ m-2
  • participating in regular physical training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: abdominal aerobic endurance exercise
Subjects were combining treadmill running at 70% HRmax (27 minutes) with 4x4minutes (30-40% maximal strength, 1RM) of torso rotation and abdominal crunches (57 minutes), 4 d per wk for 10 weeks
Subjects combined treadmill running at 70% HRmax (27 minutes) with 4x4minutes (30-40% maximal strength, 1RM) of torso rotation and abdominal crunches (57 minutes), 4 days per wk for 10 weeks
Active Comparator: Control group
Subjects performed only treadmill running (45 minutes) at 70% HRmax for 4 d per week for 10 weeks.
Subjects performed treadmill running (45 minutes) at 70% HRmax 4 days per week for 10 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trunk fat mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in trunk (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lower extremity fat mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Upper extremity fat mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Fat mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Total fat mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Total fat mass (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Body weight change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Change from pre (baseline) to post test (after 10 weeks)
Body mass index change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Change from pre (baseline) to post test (after 10 weeks)
Waist circumference (cm) change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Change from pre (baseline) to post test (after 10 weeks)
Hip circumference (cm) change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Change from pre (baseline) to post test (after 10 weeks)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Trunk lean mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in trunk (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Lower extremity lean mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in lower extremities (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Upper extremity lean mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Lean mass located in upper extremities (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Total lean mass change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Total lean mass (g) measured by dual-energy x-ray absorptiometry
Change from pre (baseline) to post test (after 10 weeks)
Maximal oxygen uptake change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
Maximal oxygen uptake by cardiopulmonary indirect calorimetry
Change from pre (baseline) to post test (after 10 weeks)
Maximal muscle strength change
Time Frame: Change from pre (baseline) to post test (after 10 weeks)
One-repetition maximum (kg) in torso rotation and abdominal crunch
Change from pre (baseline) to post test (after 10 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2005

Primary Completion (Actual)

May 1, 2006

Study Completion (Actual)

May 1, 2006

Study Registration Dates

First Submitted

March 20, 2023

First Submitted That Met QC Criteria

March 31, 2023

First Posted (Actual)

April 3, 2023

Study Record Updates

Last Update Posted (Actual)

April 3, 2023

Last Update Submitted That Met QC Criteria

March 31, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MUCSR12

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Abdominal aerobic endurance exercise

Subscribe